Signal active
Bio
Mr. Wilmot is the Senior Vice President, Chief Risk and Compliance Officer at Vertex. He is responsible for leading the company’s Global Compliance (the Office of Business Integrity & Ethics), Global Litigation & Enterprise Risk Management, and Quality Assurance organizations. Before taking on his current role in 2017, Mr. Wilmot was the chief litigation counsel and also served as the company’s interim head of Compliance and interim head of Human Resources.
His previous professional experience includes serving as the chief litigation counsel for another global pharmaceutical company and as a litigation partner with Goodwin Procter LLP. Mr. Wilmot previously was an Assistant United States Attorney in the District of Massachusetts and worked as a judicial law clerk on the State of Connecticut Supreme Court.
He has served on the boards and advisory committees of numerous nonprofit, civic, and for-profit organizations, including the Massachusetts Judicial Nominating Commission (by gubernatorial appointment), the John F. Kennedy Library Foundation, and the Boys and Girls Club of Boston. In 2010, the Boston Business Journal recognized him as one of Boston’s outstanding business leaders under the age of 40. He has also been honored as one of Boston’s most influential people of color in healthcare and life sciences.
Mr. Wilmot is a graduate of Trinity College in Hartford, Connecticut, and Suffolk University Law School in Boston.
Location
Boston, Massachusetts, United States, North America
Social
Primary Organization
1989
6
2
2
1001-5000
Biotechnology, Health Care, Pharmaceutical, Medical
Jobs history
0
N/A
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
Damian Wilmot is the Senior Vice President, Chief Risk and Compliance Officer at Vertex Pharmaceuticals, based in United States, North America. With a background in Biotechnology, Damian Wilmot has a rich history of leadership and innovation. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
1
0
Personal investment
1
Annouced Date | Organization Name | Funding Round | Money Raised |
---|---|---|---|
Aug 03, 2022 | Stackwell | Seed Round - Stackwell | 3.5M |
Partner investment
0
There is no partner investment available on this profile
Exits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.